Health Net upgraded at BofA/Merrill As previously reported, BofA/Merrill upgraded Health Net two notches to Buy from Neutral. The firm upgraded shares based on increased confidence in new revenue growth and profitability. Price target raised to $59 from $33.
Health Net downgraded to Sell from Buy at Citigroup Citigroup downgraded Health Net two notches to Sell from Buy citing the stock's 60% year-to-date rally and its belief that 2015 consensus estimates are too high. Citi thinks the company's dual enrollment in California is tracking well short of projections. It raised its price target for shares to $42 from $35.